gavin
Topics Engaged In
-
- Topic
- Voices
- Last Post
-
- Clinical utility of comprehensive genomic profiling and targeted therapy in bili
- 1
- 4 years, 3 months ago
- The pattern of mucin 5AC (MUC5AC) expression using immunohistochemistry and its
- 1
- 4 years, 3 months ago
- The prevalence of targetable genomic alterations is substantially high in rare t
- 1
- 4 years, 3 months ago
- Immunohistochemistry analyses of LAG-3 expression across different tumor types a
- 1
- 4 years, 3 months ago
- A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mu
- 1
- 4 years, 3 months ago
- Phase I study of rucaparib and irinotecan in advanced solid tumors with homologo
- 1
- 4 years, 3 months ago
- Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every t
- 1
- 4 years, 3 months ago
- Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in
- 1
- 4 years, 3 months ago
- Pilot study on outcome and antitumor efficacy of an autologous cancer cell vacci
- 1
- 4 years, 3 months ago
- Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid
- 1
- 4 years, 3 months ago
- Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb;
- 1
- 4 years, 3 months ago